Cargando…
Complement Levels at Admission Reflecting Progression to Severe Acute Kidney Injury (AKI) in Coronavirus Disease 2019 (COVID-19): A Multicenter Prospective Cohort Study
BACKGROUND: Dysregulation of complement system is thought to be a major player in development of multi-organ damage and adverse outcomes in patients with coronavirus disease 2019 (COVID-19). This study aimed to examine associations between complement system activity and development of severe acute k...
Autores principales: | Henry, Brandon M., Sinkovits, György, Szergyuk, Ivan, de Oliveira, Maria Helena Santos, Lippi, Giuseppe, Benoit, Justin L., Favaloro, Emmanuel J., Pode-Shakked, Naomi, Benoit, Stefanie W., Cooper, David S., Müller, Veronika, Iványi, Zsolt, Gál, János, Réti, Marienn, Gopcsa, László, Reményi, Péter, Szathmáry, Beáta, Lakatos, Botond, Szlávik, János, Bobek, Ilona, Prohászka, Zita Z., Förhécz, Zsolt, Csuka, Dorottya, Hurler, Lisa, Kajdácsi, Erika, Cervenak, László, Mező, Blanka, Kiszel, Petra, Masszi, Tamás, Vályi-Nagy, István, Prohászka, Zoltán |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100416/ https://www.ncbi.nlm.nih.gov/pubmed/35572977 http://dx.doi.org/10.3389/fmed.2022.796109 |
Ejemplares similares
-
Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection
por: Sinkovits, György, et al.
Publicado: (2021) -
Associations between the von Willebrand Factor—ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality
por: Sinkovits, György, et al.
Publicado: (2022) -
Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups
por: Hurler, Lisa, et al.
Publicado: (2023) -
Class switch towards spike protein-specific IgG4 antibodies after SARS-CoV-2 mRNA vaccination depends on prior infection history
por: Kiszel, Petra, et al.
Publicado: (2023) -
Decreased circulating dipeptidyl peptidase-4 enzyme activity is prognostic for severe outcomes in COVID-19 inpatients
por: Nádasdi, Ákos, et al.
Publicado: (2022)